Access to Medical products
Recommendations of the UN High Level Report on access to medicines
Regulatory Dimensions to address access for quality, efficacious, safe and affordable medical products including cancer, Hepatitis C, etc.
Use of Internet and information Technology for Accessing medical and health products (Online pharmacies).

Role of Innovation and R&D for Access to medical products, Competition law for Access to Medicines and health products, Bio-technological products, Patents as a tool of innovation, Information Technology
Access to Medical products (new/innovative Medical/ health products/ disease and dosage regimens), Infectious disease control (New initiatives for R&D (Coalition for Epidemic Preparedness Innovation (CEPI) established in January 2016) for development of vaccines for infections of epidemic potential in Ebola context
New technologies providing innovative solutions for healthcare and fostering local production

International framework for access to medicines in the context of R&D and innovation – TRIPS, patent law, competition laws, Right to Health etc.
Patent and Trademarks in standard setting in medical products
Health-related provisions in Free Trade Agreements and Regional Trade Agreements in the context of medical products

Content Coming Soon

#sdg2030_india Tweets